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Abstract
Background and Aims: Inflammatory bowel diseases (IBDs) may impair quality of life (QoL) in 
paediatric patients. We aimed to evaluate in a nationwide cohort whether patients experience QoL 
in a different way when compared with their parents.
Methods: Sociodemographic and psychosocial characteristics were prospectively acquired from 
paediatric patients and their parents included in the Swiss IBD Cohort Study. Disease activity was 
evaluated by the Paediatric Crohn’s Disease Activity Index (PCDAI) and the Paediatric Ulcerative 
Colitis Activity Index (PUCAI). We assessed QoL using the KIDSCREEN questionnaire. The QoL 
domains were analysed and compared between children and parents according to type of disease, 
parents’ age, origin, education and marital status.
Results: We included 110 children and parents (59 Crohn’s disease [CD], 45 ulcerative colitis [UC], 
6 IBD unclassified [IBDU]). There was no significant difference in QoL between CD and UC/IBDU, 
whether the disease was active or in remission. Parents perceived overall QoL, as well as ‘mood’, 
‘family’ and ‘friends’ domains, lower than the children themselves, independently of their place of 
birth and education. However, better concordance was found on ‘school performance’ and ‘physical 
activity’ domains. Marital status and age of parents significantly influenced the evaluation of QoL. 
Mothers and fathers being married or cohabiting perceived significantly lower mood, family and 
friends domains than their children, whereas mothers living alone had a lower perception of the 
friends domain; fathers living alone had a lower perception of family and mood subscores.
Conclusion: Parents of Swiss paediatric IBD patients significantly underestimate overall QoL and 
domains of QoL of their children independently of origin and education.
Key Words:  Inflammatory bowel disease; paediatric; quality of life
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1. Introduction
Inflammatory bowel disease (IBD) is a chronic disease with a 
potentially important negative impact on quality of life (QoL). It 
comprises two major disorders, ulcerative colitis (UC) and Crohn’s 
disease (CD), as well as the non-defined group of IBD unclassified 
(IBDU). Approximately 25% of all IBD patients are diagnosed dur-
ing childhood or adolescence.1–3 Worldwide, the overall incidence of 
paediatric IBD ranges from 4 to 10 cases per 100 000 per year, and 
the incidence of paediatric-onset IBD, in particular of CD, seems to 
be increasing in both developed and developing nations, although 
many countries lack accurate estimates.1,4–10
2 Children with IBD typically present with moderate to severe 
disease activity.11 Initial presentation is marked by extensive involve-
ment in up to 51% of CD and 82% of UC cases, respectively, and 
with rapid early progression.10,12 Paediatric patients often show 
recurrent attacks with phases of quiescence13,14 and most of them 
require numerous potentially stressful and complex long-term 
medications for maintaining remission and managing acute flares.15 
Symptoms of IBD, such as abdominal pain and rectal bleeding, com-
plications specific to the paediatric population, such as growth fail-
ure and pubertal delay,14,16 and medication adverse effects, as well as 
the treatment, itself are challenging for both patients and parents.17 
The impact on QoL during the critical period of childhood and ado-
lescence, including education and entry into the workforce, is often 
considerable.18 Assessment of the patient’s estimation of their QoL is 
therefore essential and may have an impact on treatment strategies.19
In paediatric IBD patients, it is crucial to also involve parents in 
the medical treatment process. Parents are, to an important extent, 
responsible for the overall development and well-being of their 
children and they need to make assumptions on how their child 
experiences its disease. Therefore, as legal representatives, parents 
should not only inform medical staff but also adapt psychological 
and physical parental support to the child according to disease activ-
ity. However, we do not know whether the parents’ perception are 
always accurate and whether the assessment of QoL from the par-
ents’ perspective is similar to that of the diseased child.
The aim of this study was to explore the difference in perception 
of the QoL of paediatric IBD patients between the patients themselves 
and their parents, using data collected in the frame of the paediatric 
sub-cohort of the Swiss IBD Cohort Study (SPIBDCS). Furthermore, 
we aimed to study factors that may affect the perception of QoL. We 
hypothesized that parents and their children with IBD do not experi-
ence the disease in the same way.
2. Materials and methods
2.1. Patients
The Swiss IBD Cohort Study (SIBDCS) was initiated in 2006. The 
SIBDS is a national prospective cohort study of IBD patients in 
Switzerland. It aims to provide up-to-date information regarding dif-
ferent aspects (among other QoL assessments) of IBD in Switzerland 
for the Swiss and international scientific community, public health 
authorities and medical staff.20 For the paediatric sub-cohort, the Swiss 
Pediatric IBD Cohort Study, physician questionnaires and patient ques-
tionnaires were adapted for paediatric patients and their parents.
Up to December 2012, 196 paediatric patients ≤16 years of age, 
diagnosed with CD, UC or IBDU according to the international Porto 
criteria,21 were included at least 4 months after diagnosis, and regis-
tered in the SIBDCS database. As described by Pittet et al.,20 patients 
were recruited from the following six university centres in Switzerland: 
Lausanne, Geneva, Bern, Basel, Zurich and St Gallen, with the 
University of Lausanne as coordinating centre and database location. 
Ethics approval was obtained for the study protocol by the ethics com-
mittees of the cantons or regions from where the patients were included, 
as well as by individual consent of patient and parents. Our study sam-
ple comprised 110 paediatric patients with available and sufficiently 
completed questionnaires from both patients and their parents.
2.2. Data collection
We retrieved data regarding QoL and clinical reporting forms of the 
SPIBDCS, including demographic variables (age, gender, country of 
birth and schooling level) and medical items (type of IBD, Paediatric 
Crohn’s Disease Activity Index [PCDAI] and Paediatric Ulcerative 
Colitis Activity Index [PUCAI]). Stratification into two age groups 
was initially performed (group 1 younger than 12 years; group 2, 
12  years or older). Results were similar in both groups, but with 
a lack of statistical significance in group 1 due to low sample size 
(n = 24). Therefore, no stratification according to age groups was 
performed. One questionnaire was completed with the child during 
a structured interview conducted by a research assistant (a trained 
IBD nurse) without the presence of his/her parents, and another 
was completed by the parents separately at home. The QoL assess-
ment was based on the KIDSCREEN-GROUP 2004 questionnaire, a 
well-validated five-domain self-report questionnaire of general QoL 
domains (‘physical activity’, ‘children’s mood’, ‘family life’, ‘friends’ 
and ‘school performance’), using a Likert scale that ranges from 0 
(never) to 5 (frequent), which was developed specifically for chil-
dren and adolescents between 8 and 18 years, appropriate for the 
life and development issues of children with chronic disease.22,23 Two 
KIDSCREEN questionnaires were thus completed – by the child 
and one by the parents – and the two were compared. A sociode-
mographic questionnaire assessing family characteristics (age, birth 
country, familial situation, parental education, number of children 
and notable life events) was completed by the parents.
2.3. Statistical analysis
We assessed the difference between overall scores and scores for each 
domain between paediatric patients and their parents. Differences in 
QoL scores were calculated as parents minus child, with a positive 
difference indicating a higher perception and a negative result a lower 
perception by parents. Parents’ perception was correlated with social, 
psychological and demographic variables as well as with the type and 
severity of disease, in order to help characterize observations. For the 
purpose of these analyses, we grouped diagnoses of UC and IBDU in 
a single category, to be compared with CD. Continuous variables were 
described using the median, interquartile range (IQR) and range. The 
differences between QoL scores for paediatric patients and their par-
ents were compared by using a Wilcoxon test for two categories and 
a Kruskal–Wallis test for three or more categories. The signed rank 
test was used to test whether the median of a single group was statisti-
cally different from a fixed value, typically 0. The effects of continuous 
covariates on differences in QoL were analysed using a linear regres-
sion. We considered p < 0.05 to be statistically significant.
3. Results
3.1. Patient characteristics
One hundred and ten paediatric patients with active IBD were 
included (55 males [50%]), of whom 59 (53.6%) presented with 
CD, 45 (40.9%) with UC and 6 (5.5%) with IBDU. Median age was 
14 years (range 7–17 years). Most of the patients (71.8%) attended 
secondary school (Table 1).
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3.2. Parent characteristics
When comparing mothers with fathers, there were only small differences 
regarding age, birth country, education level, family situation and num-
ber of children. Most of the parents were either married or cohabiting 
(70.9%) and the majority of parents were born in Switzerland (65.5% 
of mothers and 58.2% of fathers). Almost one-third of parents had basic 
education (29.1% of mothers and 27.3% of fathers), whereas nearly 
50% of all parents had attended either higher education, technical 
school or university (46.4% of mothers and 44.5% of fathers). Most of 
the parents had 2 or more children (Table 1). The vast majority of ques-
tionnaires were completed by the mother only (78.9%), whereas 10.1% 
of the parents completed it together. There was, however, no statistically 
significant difference according to whether the mother was involved 
(alone or together with the father) in completing the questionnaire.
3.3. QoL differences according to patient’s gender 
and age
Parents perceived the overall QoL of their children with IBD significantly 
lower, as well as the domains mood, family life and friends, compared 
with the patient’s own evaluation (p < 0.001). However, there was no sig-
nificant difference in QoL scores regarding the physical well-being and 
school performance domains (Figure 1). This result was consistent for 
both genders, even though there was a trend to lower perception in girls 
regarding the domains of mood (p = 0.057) and family life (p = 0.069). 
Patient’s age did not have a significant impact on evaluation of QoL.
3.4. QoL differences according to disease type and 
activity
There was no significant difference regarding the QoL differences 
between CD patients and UC/IBDU patients (Table 2). The severity 
of disease according to PCDAI and the PUCAI index was not a sig-
nificant factor for difference in QoL evaluation between parents and 
patients either. Also, patients’ hobbies did not significantly affect the 
difference in QoL between parents and children. ednav
3.5. QoL differences according to family situation
Regarding the family situation, the small number of single liv-
ing mothers/fathers (Table  1) makes a valuable statistical 
Table 1. Demographics of children and parents.
Child Mother Father
Disease
 Crohn’s disease 59 (53.6%)
 Ulcerative colitis 45 (40.9%)
 IBD unclassified 6 (5.5%)
Gender
 Male 55 (50.0%)
 Female 55 (50.0%)
Age, years (median, IQR, range) 14 (12–15, 7–17) 44 (41–47, 30–52) 47 (44–50, 35–64)
Country of birth
 Switzerland 83 (75.5%) 72 (65.4%) 64 (58.2%)
 Other 6 (5.5%) 18 (16.4%) 26 (23.6%)
 Unknown 21 (19.0%) 20 (18.2%) 20 (18.2%)
Schooling level
 Primary school 4 (3.6%)
 Secondary school 79 (71.8%)
 Special school 3 (2.7%)
 Logopaedic school 1 (0.9%)
 Private school 6 (5.5%)
 Other 12 (10.9%)
 Unknown 5 (4.6%)
Education
 None 3 (2.7%) 1 (0.9%)
 Compulsory school 1 (0.9%) 7 (6.4%)
 Basic formation 32 (29.1%) 30 (27.3%)
 Higher formation 21 (19.1%) 11 (10.0%)
 Technical school 21 (19.1%) 25 (22.7%)
 University 9 (8.2%) 13 (11.8%)
 Other 5 (4.5%) 4 (3.6%)
 Unknown 18 (16.4%) 19 (17.3%)
Family situation
 Alone 10 (9.1%) 7 (6.4%)
 Married/cohabiting 78 (70.9%) 78 (70.9%)
 Unknown 22 (20.0%) 25 (22.7%)
Number of children
 0 0 (0.0%) 1 (0.9%)
 1 9 (8.2%) 8 (7.3%)
 2 50 (45.2%) 46 (41.8%)
 3 or more 32 (29.1%) 33 (30.0%)
 Unknown 19 (17.3%) 22 (20.0%)
IQR, interquartile range
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interpretation of this subgroup difficult. Still, married and cohab-
iting mothers had a significantly lower perception of overall 
QoL (p < 0.001) and its domains mood, family and friends (all 
p < 0.001), whereas results for mothers living alone were slightly 
more concordant with those for their children. In fact, the moth-
ers’ estimates were lower only for overall QoL (p = 0.006) and 
the domain friends (p = 0.005). Results for fathers were similar: 
estimates for fathers living alone were significantly lower overall 
QoL (p = 0.022) and for the domains family (p = 0.017) and mood 
(p = 0.028), but not friends (Figure 2). The differences between 
the two groups of married/cohabiting and mothers/fathers liv-
ing alone were not significant (Figure 2). Regarding siblings, the 
lower perception of overall QoL and of the domains family and 
friends by parents was significant, independently of the number of 
siblings; the item mood was only estimated lower in the subgroup 
of patients with siblings (one sibling, p  <  0.001; two or more 
siblings, p = 0.002).
3.6. QoL differences according to background of 
parents
As mentioned above, overall QoL as well as the domains mood, 
family and friends were perceived to be lower by all parents. 
When splitting the parents into groups of parents with birthplace 
in Switzerland and abroad, this result remained significant only in 
the subgroup of mothers/fathers born in Switzerland (all p < 0.001). 
There was no significant difference regarding the level of education 
of the parents, even though parents with a higher level of education 
tended to underestimate QoL more than parents with a lower level 
of education (Table 3).
The age of the parents had an impact on the differences observed. 
As they became older, mothers significantly underestimated QoL 
regarding friends, whereas fathers significantly overestimated QoL 
regarding school, compared with their children.
The number of notable life events of mothers (none, one, two 
or more) had no significant impact on estimation of patients’ QoL.
4. Discussion
This study shows that parents in Switzerland do not experience the 
disease of their children with IBD in the same way as the patients 
themselves. They report a significantly lower overall QoL of their 
children with IBD, as well as of its sub-aspects of mood, family life 
and friends, compared with the patients themselves. Interestingly, the 
domains of school performance and physical activity did not dif-
fer. These findings might be due to the fact that parents can quite 
easily assess school performance by objective means – from school 
notes and physical activity – by simple observation of their child. 
Interpretation of a child’s mood and its’ interaction with family and 
friends, however, is more subjective and might be difficult, especially 
as children tend to not share all of their feelings and experiences with 
their parents.
Our results show that parents of Swiss paediatric IBD patients 
underestimate the QoL of their affected children. One might suspect 
that parents’ concern regarding the well-being of their children is 
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Figure  1. Difference in evaluation of patients QoL between parents and 
patients.
Table 2. Association of IBD type (CD, UC/IBDU) with difference in quality of life estimation between parents and patients.
Diagnosis CDa UC/IBDUa p-value (CD vs UC/IBDU) p-value (CD) = 0 p-value (UC) = 0
Physical 0.0 0.0 0.364 0.771 0.161
–0.6 to 0.6 –0.8 to 0.2
–2.6 to 2.0 –2.8 to 2.0
Mood –0.3 –0.4 0.395 <0.001 <0.001
–0.7 to 0.1 –0.9 to 0.0
–2.0 to 2.1 –2.1 to 2.7
Family –0.3 –0. 0.767 0.002 <0.001
–0.7 to 0.1 –0.6 to 0.0
–1.6 to 1.1 –1.7 to 1.3
Friends –0.5 –0.8 0.152 <0.001 <0.001
–1.0 to 0.0 –1.0 to –0.3
–2.5 to 2.0 –4.0 to 1.3
School 0.0 0.0 0.152 0.286 0.339
–0.3 to 0.5 –0.5 to 0.3
–1.3 to 2.3 –1.5 to 3.0
Overall –0.2 –0.3 0.152 0.001 <0.001
–0.5 to 0.1 –0.6 to –0.0
–1.4 to 1.5 –1.7 to 1.5
aData are median of the difference (a positive number denotes overestimation, a negative number underestimation by parents), interquartile range and range 
(minimum–maximum).
IBD, inflammatory bowel disease; CD, Crohn’s disease; UC, ulcerative colitis; IBDU, IBD unclassified.
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high. In fact, a recently published first assessment of the QoL esti-
mation by Swiss paediatric IBD patients by Rogler et al.24 also ana-
lysed the data of the same paediatric sub-cohort of the SPIBDCS; 
it shows moderate impairment of health-related QoL for physical 
well-being due to disease activity, but good mental well-being and 
social support and significantly higher QoL regarding autonomy and 
school variables in IBD patients compared with healthy children. It 
is possible that parents underestimate their children’s QoL, leading 
to increased parental support and therefore to a higher QoL of pae-
diatric IBD patients.
None of the assessed demographic, social or medical aspects of 
patients and their parents had a significant influence on the over-
all evaluation of QoL. Several factors concerning the patient (type 
of IBD, severity of disease, gender) and the family (parents’ educa-
tion, birth country, family structure) seemed to have a clear influ-
ence on the perception of the subdomains of QoL; however, these 
factors were non-significant. Only the parents’ age seemed to affect 
significantly the estimation of differences in QoL. These results are 
comparable to the findings of Loonen et  al.25 in the Netherlands, 
who, to the best of our knowledge, were the first to investigate the 
degree of agreement between parents and their children with IBD 
regarding health-related QoL, and they assessed factors influencing 
parent–child agreement. In accordance with our findings, they found 
that parents underestimated QoL regarding social functioning, but 
that other components, like body complaints, cognitive functioning, 
autonomy and positive and negative emotions, were rated rather 
similarly. Another study, by Kunz et al.,26 assessing adolescent IBD 
patients between 11 and 18 years in the USA, showed overestimation 
of adolescents’ QoL by parents, with lowest agreement in the aspects 
of school and social functioning; it was hypothesized in this study 
that school performance may appear better outwardly (e.g. adequate 
grade point average), while adolescents may perceive internally their 
school functioning as negatively influenced by their medical condi-
tion (e.g. concentration difficulties).
Studies in children with other chronic diseases found various 
results. Whilst Dey et al.27 found relatively high parent–child agree-
ment when examining three health status groups (children with 
mental health problems, children with physical health problems 
and healthy controls), other studies in children with chronic pain 
or cancer showed results similar to those of our study.28,29 Parents of 
children with a chronic health condition/illness perceived their chil-
dren to have significantly lower QoL than did the parents of children 
without a chronic health condition.30 Finally, Rajmil et al.31 showed 
moderate to low parent–child agreement in healthy children as well, 
and the degree of agreement lessened with the children’s age.
Children with IBD, as well as children with other chronic diseases 
like epilepsy and obesity32 and children with severe cardiovascular 
disease,33 are at risk of experiencing lower health-related QoL than 
their healthy peers,34–36 and QoL seems to worsen with age, as shown 
by some authors.31,32 As we did not compare patients with their 
healthy peers, we were not able to confirm this observation. Also, a 
trend with increasing age could not be shown because stratification 
for age was not conclusive. The assessment of QoL, including aspects 
of physical, psychological and social functioning, therefore plays an 
important role in the evaluation of the burden of this chronic illness. 
Involvement of parents in the treatment process is essential for the 
optimal adaptation of medical treatment and psychological support. 
It is therefore important to know how parents estimate the QoL of 
their sick child.
The difference in the perception of the patients’ QoL between the 
patients themselves and their parents might partially be due to under-
reporting or minimizing of symptoms by young patients with IBD, 
as a result of an adaptive reaction in order to deny the full extent 
of the disease,35,37 or by their inability to reporting psychological 
symptoms.38 It is also possible that patients report symptoms quite 
accurately to their parents, who then pathologize normal behaviour 
and over-report symptoms compared with parents of non-chroni-
cally ill children. Since QoL is subjective and individual, a certain 
difference might also be normal. In fact, in children with primar-
ily inactive IBD, fatigue was significantly higher and health-related 
QoL was significantly lower than in healthy controls.39 Results for 
children with IBD were comparable to those for children with rheu-
matological diseases and cancer.40,41 The inclusion of both patients’ 
and parents’ measures of QoL can therefore provide complementary 
perspectives.42 The discussion of differing results might also enable 
constructive communication between parents and children.43
A holistic approach in support of paediatric IBD patients is 
essential. It has been known for many years that the mental well-
being of paediatric IBD patients correlates well with psychological 
and social support.17,44 Studies have documented a significant cor-
relation of adolescents’ health-related QoL scores with satisfaction 
and degree of closeness with their social support members such as 
parents.43 Even though increased disease severity was found to cor-
relate with increased social dysfunction 45 and decreased QoL,35,39,46 
psychosocial factors such as family functioning are more predic-
tive of QoL than disease activity. Children and adolescents seem 
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Figure 2. Impact of the parents’ situation (alone, married or cohabiting) on difference in QoL estimation between parents and patients.
 by guest on M
ay 2, 2016
http://ecco-jcc.oxfordjournals.org/
D
ow
nloaded from
 
274 R. Mueller et al.
to depend more on their parents’ coping skills than their own.43 
They experience more IBD-related difficulties in school and social 
functioning with distressed mothers,47 and parent distress is linked 
to poorer health-related QoL in adolescents with IBD.48 These 
findings are also known in other chronic diseases: Hamner et al.49 
described lowered levels of physical, emotional and social func-
tioning amongst paediatric patients with cancer associated with 
parental chronic stress. Similarly to our results, they also found 
that patients’ hobbies did not significantly affect the difference in 
QoL estimation; this might also be related to the fact that psy-
chosocial factors such as family life have more influence on psy-
chological well-being than personal hobbies. There is evidence 
that chronic conditions such as IBD not only affect patients, but 
also impair parent and family functioning. In particular, mothers 
of children with IBD are more likely to express distress, to show 
increased rates of depression and to report significantly greater 
family dysfunction than mothers of healthy children.44 Vice versa, 
higher health-related QoL of patients with IBD and lower disease 
activity was associated with higher QoL of parents.50 All these 
findings underline the importance of QoL assessments and their 
interpretation.
Our study has important strengths but some limitations as well. 
Strengths of the study are the prospective cohort design, which 
included 110 patients of the cohort of Swiss paediatric IBD patients, 
using an internationally valid health-related QoL instrument, as well 
as using the skills of a specially trained study nurse undertaking the 
interview with the child in the absence of the parents. The enrolment 
of paediatric patients in the Swiss IBD cohort requires the medical 
diagnosis of active IBD, which was performed in a hospital, as well 
as informed consent by the patients and parents. Since all of the 
Table 3. Association of the parents’ formation (none or basic, higher) with difference in QoL estimation between parents and patients.
Mother’s educationa
None or basic Higher p-value (none vs higher) p-value (none) = 0 p-value (higher) = 0
Physical –0.2 0.0 0.519 0.171 0.634
–0.6 to 0.2 –0.7 to 0.5
–2.2 to 2.0 –2.6 to 2.0
Mood –0.3 –0.4 0.849 0.002 0.001
–0.7 to 0.1 –0.7 to 0.0
–2.0 to 2.7 –1.7 to 2.1
Family –0.1 –0.4 0.137 0.025 0.001
–0.4 to 0.1 –0.7 to 0.1
–1.0 to 1.3 –1.7 to 1.0
Friends –0.3 –0.8 0.139 0.005 <0.001
–1.0 to 0.3 –1.0 to –0.3
–4.0 to 1.3 –2.5 to 2.0
School 0.0 0.0 0.668 0.568 0.967
–0.5 to 0.5 –0.3 to 0.5
–1.0 to 3.0 –1.5 to 1.8
Overall –0.2 –0.3 0.303 0.004 <0.001
–0.5 to 0.0 –0.6 to 0.0
–1.4 to 1.5 –1.7 to 1.5
Father’s education
None or basic Higher p-value (none vs higher) p-value (none) = 0 p-value (higher) = 0
Physical 0.0 –0.2 0.195 0.795 0.102
–0.6 to 0.5 –0.8 to 0.4
–1.8 to 2.0 –2.6 to 2.0
Mood –0.3 –0.4 0.393 0.016 <0.001
–0.7 to 0.1 –0.7 to 0.0
–2.0 to 2.7 –1.7 to 2.1
Family –0.1 –0.4 0.428 0.039 <0.001
–0.6 to 0.1 –0.7 to 0.1
–1.6 to 1.3 –1.7 to 1.0
Friends –0.3 –0.8 0.114 0.003 <0.001
–1.0 to 0.3 –1.1 to –0.1
–2.0 to 1.3 –4.0 to 2.0
School 0.3 –0.1 0.088 0.124 0.394
–0.3 to 0.5 –0.5 to 0.4
–1.3 to 3.0 –1.5 to 1.8
Overall –0.1 –0.3 0.052 0.081 <0.001
–0.4 to 0.1 –0.6 to –0.1
–1.4 to 1.5 –1.7 to 1.5
aData in the education columns are median of the difference (a positive number denotes overestimation, a negative number underestimation by parents; inter-
quartile range and range (minimum–maximum).
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tertiary hospital centres in Switzerland participated in data collec-
tion, we assume that the cohort is representative of the overall Swiss 
paediatric IBD patient population. The questionnaires contained 
easily understandable questions. They have been validated and were 
available in several languages and the paediatric patient was helped 
by a trained IBD nurse without his/her parents being present, thus 
minimizing the risk of children up-scaling their responses to please 
their parents.
Unfortunately, 86 patients and/or their parents did not complete 
the questionnaires regarding QoL, which is the major limitation of 
our study, and no data are available for comparison if the parents/
patients who did not complete the QoL questionnaire were more 
often depressed or less educated. However, when comparing the dis-
ease activity indexes of the entire cohort (196 patients), no significant 
difference could be seen between responders and non-responders 
(p  = 0.430 for CD and p  = 0.618 for UC). Even though we con-
sider our cohort to be representative, since every single child with 
diagnosed IBD is invited to join the IBD cohort, we cannot exclude 
an undefined selection bias, as some paediatric patients might also 
be followed up by adult gastroenterologists not participating in 
the Swiss IBD cohort study. Other methodological limitations are 
related to the character of the questionnaires: discussions between 
the parents (mother and father) whilst filling in their individual ques-
tionnaire might have affected the evaluation of QoL by the parents. 
The fact that only 10% of questionnaires were completed by both 
parents together renders this risk negligible. Other methodological 
limitations are related to the retrospective character of the question-
naires: patients and their parents had to report facts related mainly 
to the past, e.g. school performance or family life of the last few 
months, with the risk that the remembered information provided 
was not accurate. Finally it cannot be excluded that children try to 
avoid communicating their concerns.
In conclusion, the present cohort study clearly shows that Swiss 
IBD patients and their parents do not experience the disease of the 
child or adolescent in the same way. The uniform and validated 
questionnaires, filled in separately by paediatric patients and their 
parents, represent a valuable instrument in the evaluation of health-
related QoL of paediatric IBD patients in Switzerland in order to 
further improve their care, as it opens fields of discussion for com-
munication between parents and their affected children.
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